IL6 and systemic lupus erythematosus: These results suggest that treatment with anti-IL-6 mAb has a beneficial effect on autoimmunity in murine SLE and that autoreactive B cells may be the primary target for anti-IL-6 MAB treatment; its effect on autoreactive T cells is also indicated [43].